Patents by Inventor Michael Sasse

Michael Sasse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190359049
    Abstract: A torque transmission assembly (20) for a drive system of a vehicle, includes a housing (26), an input-side friction surface arrangement which is coupled to the housing (26) for corotation around a rotational axis (A), an output-side friction surface arrangement which is coupled to a drive member (36) for corotation around the rotational axis (A) and a deflection mass arrangement (50) with a deflection mass carrier (52) and at least one deflection mass (54) supported at the deflection mass carrier (52) and which can be deflected from a basic relative position with respect to the deflection mass carrier (52). The torque transmission assembly (20) does not comprise a torsional vibration damper arrangement, and/or the deflection mass carrier (52) is connected to the housing (26) so as to be fixed with respect to rotation relative to the housing for corotation around the rotational axis (A).
    Type: Application
    Filed: December 18, 2017
    Publication date: November 28, 2019
    Inventors: Michael WIRACHOWSKI, Sebastian NEUGEBAUER, Andreas ORLAMÜNDER, Christoph SASSE, Christoph FAUSS, Stefan HERZOG
  • Publication number: 20070203200
    Abstract: A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, characterised in that it: (i) comprises water in the range of from 0.4 to 2.5% w/w; and (ii) provides an infra red spectrum containing peaks at 1749, 1703, 1645, 1623, 1365 and 736 cm?1; and/or (iii) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in FIG. II and/or (iv) provides a Raman spectrum containing peaks at 3106, 3069, 3002, 2961, 1750, 1718, 1684, 1385, 1335, 1229, 1078, 917, 428 and 349 cm?1 and/or (iv) provides a solid-state nuclear magnetic resonance spectrum containing chemical shifts substantially as set out in Table I; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.
    Type: Application
    Filed: May 3, 2007
    Publication date: August 30, 2007
    Inventors: Michael Sasse, Paul BLACKLER, David Lee
  • Publication number: 20070167494
    Abstract: A crystallization process for preparing a polymorph of rosiglitazone maleate (Compound 1), and a process for preparing Compound 1 with a polymorphic purity that is suitable for use as a seed material in a crystallization process for preparing Compound 1.
    Type: Application
    Filed: March 25, 2004
    Publication date: July 19, 2007
    Inventors: Andrew Craig, Robert Giles, Jonathan Smithers, Tim Ho, Michael Sasse
  • Publication number: 20070037859
    Abstract: A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt., characterised in that it: (i) comprises water in the range of from 0.3 to 0.6 molar equivalents; and (ii) provides an infra red spectrum containing peaks at 1757, 1331, 1290, 1211 and 767 cm?1; and/or (iii) provides a Raman spectrum containing peaks at 1758, 1610, 1394, 1316 and 1289 cm?1; and/or (iv) provides a solid state nuclear magnetic resonance spectrum containing chemical shifts substantially as set out in Table I herein; and/or (v) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in FIG. IV herein; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.
    Type: Application
    Filed: September 28, 2006
    Publication date: February 15, 2007
    Inventors: Ian Lynch, Michael Sasse, Bernadette Choudary
  • Publication number: 20060247279
    Abstract: A polymorphic form of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt (the “Polymorph”) characterised in that it provides: (i) an infra red spectrum containing peaks at 1752, 1546, 1154, 621, and 602 cm?1; and/or (ii) a Raman spectrum containing peaks at 1751, 1243 and 602 cm?1; and/or (iii) a solid-state nuclear magnetic resonance spectrum containing peaks at 111.9, 114.8, 119.6, 129.2, 134.0, 138.0, 144.7, 153.2, 157.1, 170.7, 172.0, and 175.0 ppm; and/or (iv) an X-ray powder diffraction (XRPD) pattern which gives calculated lattice spacings of 6.46, 5.39, 4.83, 4.68, 3.71, 3.63, 3.58, and 3.48 Angstroms; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 19, 2006
    Publication date: November 2, 2006
    Inventors: Paul Blackler, Robert Giles, Stephen Moore, Michael Sasse
  • Publication number: 20060189659
    Abstract: A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, characterised in that it: (i) comprises water in the range of from 0.2 to 1.1% w/w ; and (ii) provides an infra red spectrum containing peaks at 764 and 579 cm?1; and/or (iii) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in Figure II; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.
    Type: Application
    Filed: March 16, 2006
    Publication date: August 24, 2006
    Inventors: Michael Sasse, Paul David Blackler, David Lee
  • Publication number: 20050288513
    Abstract: A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl)thiazolidine-2,4-dione, maleic acid salt, characterized in that it: (i) comprises water in the range of from 0.3 to 0.6 molar equivalents; and (ii) provides an infra red spectrum containing peaks at 1757, 1331, 1290, 1211 and 767 cm?1; and/or (iii) provides a Raman spectrum containing peaks at 1758, 1610, 1394, 1316 and 1289 cm?1; and/or (iv) provides a solid state nuclear magnetic resonance spectrum containing chemical shifts substantially as set out in Table I herein; and/or (v) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in Figure IV herein; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.
    Type: Application
    Filed: August 17, 2005
    Publication date: December 29, 2005
    Inventors: Ian Lynch, Michael Sasse, Bernadette Choudary
  • Patent number: 6815457
    Abstract: A polymorphic form of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]-benzyl]thiazolidine-2,4-dione, maleic acid salt (the “Polymorph”) characterized in that it: (i) provides an infra red spectrum containing peaks at 1360, 1326, 1241, 714 and 669 cm−1; and/or (ii) provides a Raman spectrum containing peaks at 1581, 768, 670, 271 and 226 cm−1; and/or (iii) provides a solid-state nuclear magnetic resonance spectrum containing peaks at chemical shifts substantially as set out in Table I; and/or (iv) provides an X-ray powder diffraction (XRPD) pattern containing peaks substantially as set out in Table II; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: November 9, 2004
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Paul David James Blackler, Robert Gordon Giles, Michael Sasse
  • Patent number: 6068302
    Abstract: The invention relates to a joining connection of at least one exhaust-gas-carrying pipe of an internal-combustion engine having a fastening flange which is inserted in its duct and, on its opening edge situated inside the duct, is welded to the duct wall of the flange, and to a process for its manufacture. In order to provide in a simple manner an automating capacity of the manufacture of the joining connection which is reliable with respect to the process, at least one support projection is constructed in an axially position-defined manner on the duct wall. The support projection projects into the duct and the pipe rests directly on the support projection in the plug-in position in the axial direction. The interior wall of the pipe ends flush with the end edge or projects radially beyond it toward the inside.
    Type: Grant
    Filed: November 20, 1997
    Date of Patent: May 30, 2000
    Assignee: DaimlerChrysler AG
    Inventors: Michael Sasse, Jurgen Schmidt